| Dr Cosmo Filiberto, MD | |
|
112 Quarry Rd, Suite 120, Trumbull, CT 06611-4816 | |
| (203) 372-4065 | |
| (203) 372-1644 |
| Full Name | Dr Cosmo Filiberto |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 48 Years |
| Location | 112 Quarry Rd, Trumbull, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144209321 | NPI | - | NPPES |
| 001219401 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 021940 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| Rehabilitation Associates Inc | 8022905322 | 297 |
News Archive
That's how fast signups would have to be happening for the health law to "pass its first physical," reports The Associated Press. Meanwhile, health consultant Avalere projects that 5.4 million are actually on track to sign up for coverage by March 31.
Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.
The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).
Medivir AB, the emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that NASDAQ OMX Stockholm is promoting Medivir AB (MVIR B) from the Small Cap to the Mid Cap List. The change is effective as of January 3, 2011.
› Verified 9 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
That's how fast signups would have to be happening for the health law to "pass its first physical," reports The Associated Press. Meanwhile, health consultant Avalere projects that 5.4 million are actually on track to sign up for coverage by March 31.
Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.
The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).
Medivir AB, the emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that NASDAQ OMX Stockholm is promoting Medivir AB (MVIR B) from the Small Cap to the Mid Cap List. The change is effective as of January 3, 2011.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cosmo Filiberto, MD 112 Quarry Rd, Suite 120, Trumbull, CT 06611-4816 Ph: (203) 372-4065 | Dr Cosmo Filiberto, MD 112 Quarry Rd, Suite 120, Trumbull, CT 06611-4816 Ph: (203) 372-4065 |
News Archive
That's how fast signups would have to be happening for the health law to "pass its first physical," reports The Associated Press. Meanwhile, health consultant Avalere projects that 5.4 million are actually on track to sign up for coverage by March 31.
Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.
The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).
Medivir AB, the emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that NASDAQ OMX Stockholm is promoting Medivir AB (MVIR B) from the Small Cap to the Mid Cap List. The change is effective as of January 3, 2011.
› Verified 9 days ago
Gerardo Elias Tolentino, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd Ste 120, Trumbull, CT 06611 Phone: 203-372-4065 Fax: 203-372-1644 | |
Pritee Gada, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 120, Trumbull, CT 06611 Phone: 203-372-4065 Fax: 203-372-1644 | |
Dr. Corey Jaquez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Church Hill Rd, Trumbull, CT 06611 Phone: 203-696-3550 | |
Milla Stelman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 120, Trumbull, CT 06611 Phone: 203-372-4065 Fax: 203-372-1644 | |
Dr. Deborah Pinto, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Corporate Dr, Trumbull, CT 06611 Phone: 203-268-8673 Fax: 203-268-8674 | |
Bhawna Gupta, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5520 Park Ave, Ste. 206, Trumbull, CT 06611 Phone: 203-371-7177 |